CITES
Overview
CITES is a venture capital firm based in Argentina that supports the development of scientific and technological startups. It focuses on transforming disruptive science into scalable businesses by investing in early-stage companies with innovative ideas that address significant societal challenges. CITES offers comprehensive support, including business management, intellectual property guidance, and access to fully equipped laboratories for up to two years. The firm operates in sectors such as Insurtech, Fintech, ICT, Edutech, Agtech, Pharma, Healthtech, and Life Science. CITES invests in early-stage companies, providing funding and incubation services to foster growth and innovation. The firm is committed to promoting scientific-technological entrepreneurship in Argentina, aiming to strengthen the scientific, economic, and social development of the region and the country. CITES has a track record of investing in various startups, contributing to the growth of the entrepreneurial ecosystem in Argentina. Its investment philosophy emphasizes the importance of knowledge and talent in driving societal change and progress, focusing on turning innovative ideas into successful businesses that have a positive impact on society. CITES operates with a team of experienced professionals dedicated to addressing both technological and business challenges, offering interdisciplinary support to entrepreneurs seeking to transform their ideas into viable companies.
Investment Focus
- Innovative ideas addressing societal challenges
- Early-stage companies
- Focus on sectors such as Insurtech, Fintech, ICT, Edutech, Agtech, Pharma, Healthtech, and Life Science
Portfolio Companies
Reach CITES directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about CITES
What sectors does CITES invest in?
CITES invests in HealthTech, FinTech, InsurTech, Agtech, ICT and EduTech, and is based in Châtelaine, Genève, Switzerland. CITES is listed as a venture capital in the ConnectSafely investor database.
What stage does CITES invest at?
CITES backs companies at Seed and Early Stage.
Which regions does CITES invest in?
CITES invests across Argentina.
Who are the partners at CITES?
Team members listed for CITES include Kristina Rodina (Chief of Outreach and Projects Unit).
What companies has CITES invested in?
CITES's portfolio includes Ergo Bioscience, Ardan, Eolo Pharma, ViewMind Inc, Single Strand Biotech, Circa Therapeutics, Ab Astra and NeuroAcoustics.
How do I contact CITES?
CITES's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
